120 related articles for article (PubMed ID: 10381167)
1. Intracellular activation of 2',3'-dideoxyinosine and drug interactions in vitro.
Kewn S; Hoggard PG; Henry-Mowatt JS; Veal GJ; Sales SD; Barry MG; Back DJ
AIDS Res Hum Retroviruses; 1999 Jun; 15(9):793-802. PubMed ID: 10381167
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamic studies (PD) of didanosine (ddI) alone and in combination with azidothymidine (AZT) in human T-cells; a stochastic biochemical approach to antiretroviral nucleoside drug combination in inhibiting HIV-reverse transcriptase (RT).
Periclou AP; Nandy P; Avramis VI
In Vivo; 2000; 14(3):377-88. PubMed ID: 10904870
[TBL] [Abstract][Full Text] [Related]
3. Effect of protease inhibitors on nucleoside analogue phosphorylation in vitro.
Hoggard PG; Manion V; Barry MG; Back DJ
Br J Clin Pharmacol; 1998 Feb; 45(2):164-7. PubMed ID: 9491831
[TBL] [Abstract][Full Text] [Related]
4. Lamivudine (3TC) phosphorylation and drug interactions in vitro.
Kewn S; Veal GJ; Hoggard PG; Barry MG; Back DJ
Biochem Pharmacol; 1997 Sep; 54(5):589-95. PubMed ID: 9337075
[TBL] [Abstract][Full Text] [Related]
5. Uptake and distribution of 2',3'-dideoxyinosine and its derivatives in a human monocytoid cell line.
Vázquez-Padua MA; Mayol N; López M
Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S113-9. PubMed ID: 8574139
[TBL] [Abstract][Full Text] [Related]
6. Effect of hydroxyurea and dideoxyinosine on intracellular 3'-deoxyadenosine-5'-triphosphate concentrations in HIV-infected patients.
Bakshi RP; Hamzeh F; Frank I; Eron JJ; Bosch RJ; Rosenkranz SL; Cramer YS; Ussery M; Flexner C
AIDS Res Hum Retroviruses; 2007 Nov; 23(11):1360-5. PubMed ID: 18184078
[TBL] [Abstract][Full Text] [Related]
7. Interpretation of the roles of adenylosuccinate lyase and of AMP deaminase in the anti-HIV activity of 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine.
Nair V; Sells TB
Biochim Biophys Acta; 1992 Feb; 1119(2):201-4. PubMed ID: 1540653
[TBL] [Abstract][Full Text] [Related]
8. Cellular phosphorylation of 2',3'-dideoxyadenosine-5'-monophosphate, a key intermediate in the activation of the antiviral agent DDI, in human peripheral blood mononuclear cells.
Robbins BL; Greenhaw J; Fridland A
Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):405-13. PubMed ID: 10772723
[TBL] [Abstract][Full Text] [Related]
9. Determination of ddATP levels in human immunodeficiency virus-infected patients treated with dideoxyinosine.
Le Saint C; Terreux R; Duval D; Durant J; Ettesse H; Dellamonica P; Guedj R; Vincent JP; Cupo A
Antimicrob Agents Chemother; 2004 Feb; 48(2):589-95. PubMed ID: 14742213
[TBL] [Abstract][Full Text] [Related]
10. In vitro analysis of synergism and antagonism of different nucleoside/nucleotide analogue combinations on the inhibition of human immunodeficiency virus type 1 replication.
Perez-Olmeda M; Garcia-Perez J; Mateos E; Spijkers S; Ayerbe MC; Carcas A; Alcami J
J Med Virol; 2009 Feb; 81(2):211-6. PubMed ID: 19107982
[TBL] [Abstract][Full Text] [Related]
11. Intracellular nucleotide levels during coadministration of tenofovir disoproxil fumarate and didanosine in HIV-1-infected patients.
Hawkins T; Veikley W; Durand-Gasselin L; Babusis D; Reddy YS; Flaherty JF; Ray AS
Antimicrob Agents Chemother; 2011 Apr; 55(4):1549-55. PubMed ID: 21282432
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of IMP dehydrogenase stimulate the phosphorylation of the anti-human immunodeficiency virus nucleosides 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine.
Hartman NR; Ahluwalia GS; Cooney DA; Mitsuya H; Kageyama S; Fridland A; Broder S; Johns DG
Mol Pharmacol; 1991 Jul; 40(1):118-24. PubMed ID: 1677450
[TBL] [Abstract][Full Text] [Related]
13. Correlation between intracellular pharmacological activation of nucleoside analogues and HIV suppression in vitro.
Hoggard PG; Sales SD; Kewn S; Sunderland D; Khoo SH; Hart CA; Back DJ
Antivir Chem Chemother; 2000 Nov; 11(6):353-8. PubMed ID: 11227992
[TBL] [Abstract][Full Text] [Related]
14. The intracellular activation of lamivudine (3TC) and determination of 2'-deoxycytidine-5'-triphosphate (dCTP) pools in the presence and absence of various drugs in HepG2 cells.
Kewn S; Hoggard PG; Sales SD; Johnson MA; Back DJ
Br J Clin Pharmacol; 2000 Dec; 50(6):597-604. PubMed ID: 11136299
[TBL] [Abstract][Full Text] [Related]
15. 5-Amino-4-imidazolecarboxamide riboside potentiates the metabolism and anti-human immunodeficiency virus activity of 2',3'-dideoxyinosine.
Gong YF; Srinivas RV; Fridland A
Mol Pharmacol; 1993 Jul; 44(1):30-6. PubMed ID: 8341276
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of 2',3'-dideoxy-2',3'-didehydro-beta-L(-)-5-fluorocytidine and its activity in combination with clinically approved anti-human immunodeficiency virus beta-D(+) nucleoside analogs in vitro.
Dutschman GE; Bridges EG; Liu SH; Gullen E; Guo X; Kukhanova M; Cheng YC
Antimicrob Agents Chemother; 1998 Jul; 42(7):1799-804. PubMed ID: 9661024
[TBL] [Abstract][Full Text] [Related]
17. Analysis and validation of the phosphorylated metabolites of two anti-human immunodeficiency virus nucleotides (stavudine and didanosine) by pressure-assisted CE-ESI-MS/MS in cell extracts: sensitivity enhancement by the use of perfluorinated acids and alcohols as coaxial sheath-liquid make-up constituents.
Bezy V; Chaimbault P; Morin P; Unger SE; Bernard MC; Agrofoglio LA
Electrophoresis; 2006 Jun; 27(12):2464-76. PubMed ID: 16786481
[TBL] [Abstract][Full Text] [Related]
18. Enzymatic phosphorylation and pyrophosphorylation of 2',3'-dideoxyadenosine-5'-monophosphate, a key metabolite in the pathway for activation of the anti-HIV (human immunodeficiency virus) agent 2',3'-dideoxyinosine.
Navé JF; Eschbach A; Wolff-Kugel D; Halazy S; Balzarini J
Biochem Pharmacol; 1994 Sep; 48(6):1105-12. PubMed ID: 7945403
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of nucleoside analogs on oxidative phosphorylation in human pancreatic cells.
Lake-Bakaar G; Mazzoccoli V; Dickman K; Lyubsky S
Dig Dis Sci; 2001 Sep; 46(9):1853-63. PubMed ID: 11575436
[TBL] [Abstract][Full Text] [Related]
20. In vitro screening of nucleoside analog combinations for potential use in anti-HIV therapy.
Veal GJ; Barry MG; Khoo SH; Back DJ
AIDS Res Hum Retroviruses; 1997 Apr; 13(6):481-4. PubMed ID: 9100989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
